3 Ways To Adopt A Quality Management Maturity Model In Drug Manufacturing

By Ave Anderegg

Trends in quality management show that supply chain disruptions continue to pose a threat to pharmaceutical companies and have a far-reaching impact on the entire healthcare ecosystem. The U.S. Food and Drug Administration (FDA) is keenly aware of this impact and is intent on remediating it.

The FDA’s Center for Drug Evaluation and Research (CDER) released a white paper revisiting a proposed public quality management maturity (QMM) rating system that outlined their desire for pharmaceutical companies to operate on a QMM model. The objective of quality management maturity (QMM) is to elevate quality beyond the base level of current good manufacturing practices. This can be accomplished readily by adopting a digital quality management software solution. Explore three practical paths to pharma QMM and the key benefits of using a digital pharma QMS.